Astonishing Growth in Artificial Heart and Assist Devices Industry

Astonishing Growth in Artificial Heart and Assist Devices Industry

An artificial heart is a device that replaces the heart. Artificial hearts are typically used to bridge the gap before a heart transplant or to permanently replace the heart if a heart transplant is impossible. Although other similar inventions preceded it from the late 1940s, the first artificial heart to be successfully implanted in a human was the 1982 Jarvik-7, designed by a team of Willem Johan Kolff and Robert Jarvik.

Get Sample PDF

Some of the key players of Artificial Heart and Assist Devices Industry:

BiVACOR, SynCardia, Jarvik Heart, CARMAT, AbioMed, LivaNova (Sorin), Getinge (Maquet), Medtronic, Terumo CV Group, Braile Biomedica, Tianjin Medical

An artificial heart is different from a ventricular assist device (VAD), which is designed to assist with heart failure. It is also different from a cardiopulmonary bypass machine, which is an external device that provides the functions of the heart and lungs. It is only used for a few hours at a time, most commonly during heart surgery.

A synthetic lung replacement remains a long-awaited "holy grail" in modern medicine. The obvious benefit of having a functioning artificial heart would be to reduce the need for lung transplants as the demand for organs always greatly outweighs supply.

Comments

Popular posts from this blog

Cystoscope Market Estimate to Boost Growth in Demand by 2027 with Top Key Players: Henke-Sass Wolf, Olympus Corporation, Stryker, NeoScope Inc., KARL STORZ SE & Co. KG

Future Scope for Deep Sea Exploration Robot Industry

Huge Demand for Weather Radar Industry